Neovasc Inc. T.NVC

Primary Symbol: NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc.

<< Previous

Bullboard Posts

Next >>

Post by mcdotcaon Jun 12, 2020 11:07am

432 Views

Post# 31143337

180 Days from PMA Submission

I'm not sure how much Covid has or will impact the standard review process of the PMA application but I've read that the FDA requires 180 days. It was accepted for review Jan 15 so we should be very close to hearing either fantastic or awful news for the Reducer.

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”